share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Taraporevala Cyrus

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Taraporevala Cyrus

輝瑞 | 4:持股變動聲明-董事 Taraporevala Cyrus
美股sec公告 ·  07/01 19:29
Moomoo AI 已提取核心訊息
Cyrus Taraporevala, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock on June 27, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, have not been disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding Pfizer stock.
Cyrus Taraporevala, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock on June 27, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, have not been disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding Pfizer stock.
輝瑞公司[PFE]的報告人Cyrus Taraporevala於2024年6月27日參與了一筆公司股票交易。公告沒有透露交易的具體細節,包括交易類型、狀態幣、涉及的股份數量、股份的性質、交易價格和交易後的參股金融信息。投資者應等待進一步信息,以充分了解此事件對於其有效的投資決策可能產生的影響。
輝瑞公司[PFE]的報告人Cyrus Taraporevala於2024年6月27日參與了一筆公司股票交易。公告沒有透露交易的具體細節,包括交易類型、狀態幣、涉及的股份數量、股份的性質、交易價格和交易後的參股金融信息。投資者應等待進一步信息,以充分了解此事件對於其有效的投資決策可能產生的影響。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息